156 related articles for article (PubMed ID: 3524827)
1. Abbreviated phase I clinical trial of i.v. mitozolomide.
Joss RA; Ryssel HJ; Bischoff AK; Goldhirsch A; Brunner KW
Cancer Treat Rep; 1986 Jun; 70(6):797-8. PubMed ID: 3524827
[No Abstract] [Full Text] [Related]
2. Phase I clinical trial of mitozolomide.
Newlands ES; Blackledge G; Slack JA; Goddard C; Brindley CJ; Holden L; Stevens MF
Cancer Treat Rep; 1985; 69(7-8):801-5. PubMed ID: 4016790
[TBL] [Abstract][Full Text] [Related]
3. [1st experiences in the treatment of ovarian tumors with Peptichemio].
Natale N; Mangioni C; Remotti G
Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233
[No Abstract] [Full Text] [Related]
4. [Results of 18 months of chemotherapy with Peptichemio].
Battelli T; Bonsignori M; Manocchi P; Perilli A
Minerva Med; 1974 Sep; 65(62):3235-43. PubMed ID: 4609310
[No Abstract] [Full Text] [Related]
5. [Recent clinical experiences in the treatment of solid tumors with Peptichemio alone or in combination].
Paparopoli G
G Ital Chemioter; 1974; 21(1):33-5. PubMed ID: 4619385
[No Abstract] [Full Text] [Related]
6. Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies.
Tura S; Mazza P; Gherlinzoni F; Zinzani PL; Poletti G; Visani G; Lemoli RM; Bandini G; Cavo M; Galieni P
Haematologica; 1988; 73(6):503-8. PubMed ID: 3148513
[No Abstract] [Full Text] [Related]
7. Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW; Weiss RB; Korzun AH; Wood WC; Carey RW; Panasci LC
Cancer Treat Rep; 1985; 69(7-8):919-20. PubMed ID: 3893695
[No Abstract] [Full Text] [Related]
8. A phase I study of bendamustine hydrochloride administered once every 3 weeks in patients with solid tumors.
Rasschaert M; Schrijvers D; Van den Brande J; Dyck J; Bosmans J; Merkle K; Vermorken JB
Anticancer Drugs; 2007 Jun; 18(5):587-95. PubMed ID: 17414628
[TBL] [Abstract][Full Text] [Related]
9. [The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds].
Kholodnyi MD; Mindlin SS
Vopr Onkol; 1969; 15(8):27-32. PubMed ID: 4982329
[No Abstract] [Full Text] [Related]
10. Randomized phase II trial of TCNU versus mitozolomide in malignant melanoma. EORTC Early Clinical Trials Group.
Smyth JF; Gundersen S; Renard J; Pinedo HM
Eur J Cancer Clin Oncol; 1989 Apr; 25(4):755-7. PubMed ID: 2714350
[No Abstract] [Full Text] [Related]
11. Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
Eichbaum MH; Schuetz F; Khbeis T; Lauschner I; Foerster F; Sohn C; Schneeweiss A
Anticancer Drugs; 2007 Sep; 18(8):963-8. PubMed ID: 17667603
[TBL] [Abstract][Full Text] [Related]
12. Phase II evaluation of mitozolomide in ovarian cancer.
Harding M; Northcott D; Smyth J; Stuart NS; Green JA; Newlands E
Br J Cancer; 1988 Jan; 57(1):113-4. PubMed ID: 3348943
[No Abstract] [Full Text] [Related]
13. Bendamustine: a novel cytotoxic agent for hematologic malignancies.
Blumel S; Goodrich A; Martin C; Dang NH
Clin J Oncol Nurs; 2008 Oct; 12(5):799-806. PubMed ID: 18842536
[TBL] [Abstract][Full Text] [Related]
14. A phase II clinical trial of peptichemio. Clinical screening cooperative group of European Organisation on Research on Treatment of Cancer (E.O.R.T.C).
Biomedicine; 1977 Nov; 27(8):290-4. PubMed ID: 339970
[No Abstract] [Full Text] [Related]
15. Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group.
Somers R; Santoro A; Verweij J; Lucas P; Rouëssé J; Kok T; Casali A; Seynaeve C; Thomas D
Eur J Cancer; 1992; 28A(4-5):855-7. PubMed ID: 1524907
[No Abstract] [Full Text] [Related]
16. Carboplatin, an active drug in advanced head and neck cancer.
de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F
Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443
[TBL] [Abstract][Full Text] [Related]
17. Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
van Oosterom AT; Stoter G; Bono AV; Splinter TA; Fossa SD; Verbaeys AJ; de Mulder PH; de Pauw M; Sylvester R
Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1249-50. PubMed ID: 2767112
[No Abstract] [Full Text] [Related]
18. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
Németh A; Morvay J; Vécsei B
Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
[No Abstract] [Full Text] [Related]
19. Phase II trial of mitozolomide in patients with advanced ovarian cancer. A study of the EORTC Gynecological Cancer Cooperative Group.
Neijt JP; van der Burg ME; Guastalla JP; George M; Piccart M; Vermorken J; Carnino F; Rotmensz N
Acta Oncol; 1989; 28(5):663-5. PubMed ID: 2590542
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of carboplatin in patients with ovarian carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
Eisenhauer EA; Swenerton KD; Sturgeon JF; Fine S; O'Reilly SE
Cancer Treat Rep; 1986 Oct; 70(10):1195-8. PubMed ID: 3530446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
